Medico Remedies Limited has informed the Exchange regarding Change in Director(s) of the company.
MEDICO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.5 pts more than Nifty Microcap 250 and 3.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Medico Remedies' board, at its meeting on 30 July 2025, cleared several changes. Mr. Harshit Mehta has been re-appointed as Managing Director for another 3 years effective 17 September 2025, subject to shareholder approval. Mr. Haresh Mehta, the founding member and current Chairman & Whole-Time Director, will continue in his role even as he turns 70 in August 2025, also pending shareholder nod. The board also appointed Mr. Maheshkumar Darji, the company's current General Manager-Plant with 20+ years in pharma, as an Additional Executive Director. Separately, Secretarial Auditor Mr. Haresh Sanghvi stepped down citing medical reasons, and Ms. Shreya Shah has been appointed as the new Secretarial Auditor for a 5-year term (FY2025-26 to FY2029-30). The notice for the 31st AGM was also approved.
These are largely routine governance housekeeping items. The Mehta family continues to dominate the board, with no change in promoter control or independent oversight. The mid-term exit of the secretarial auditor is for health reasons, not governance concerns, and a replacement is already in place.